首页|高原缺氧对血脑屏障中ATP-结合盒转运蛋白表达的影响

高原缺氧对血脑屏障中ATP-结合盒转运蛋白表达的影响

扫码查看
目的 研究高原缺氧对血脑屏障(BBB)中ATP-结合盒(ABC)转运蛋白表达的影响,并探讨影响其表达的机制.方法 将Wistar大鼠分为1500 m组(兰州实地)、4010 m组(模拟,低压氧舱,缺氧3 d)、6000 m组(模拟,低压氧舱,缺氧3 d)、苯妥英钠+1500 m组(在1500 m组基础上给予50 mg·kg-1苯妥英钠)、苯妥英钠+4010 m组(在4010 m组基础上给予50 mg·kg-1苯妥英钠)、苯妥英钠+6000 m组(在6000 m组基础上给予50 mg·kg-1苯妥英钠)和缺氧1 d组、缺氧2 d组、缺氧3 d组、缺氧4 d组(模拟海拔4010 m,低氧氧舱,分别缺氧1、2、3和4 d).用蛋白质印迹法检测BBB组织蛋白的表达水平,用高效液相色谱联用质谱法检测脑脊液苯妥英钠的浓度.结果 1500 m、4010 m、6000 m组的P-糖蛋白(P-gp)蛋白相对表达水平分别为1.00±0.04、1.84±0.02和2.10±0.05,多药耐药相关蛋白-4(MRP4)蛋白相对表达水平分别为1.00±0.05、2.77±0.08和4.42±0.03,苯妥英钠在脑脊液中的浓度为(864.78±348.32)、(1 000.22±273.90)和(1 214.17±314.09)ng·mL-1.1500 m组、4010 m组上述指标和6000 m组相比较,在统计学上差异均有统计学意义(均P<0.05).缺氧1 d组、缺氧2 d组、缺氧3 d组、缺氧4 d组P-gp蛋白相对表达水平分别为 1.00±0.03、1.85±0.04、3.10±0.02 和 2.17±0.05,MRP4 蛋白相对表达水平分别为 1.00±0.05、1.79±0.10、1.60±0.08和 1.31±0.06,缺氧1 d组、缺氧2 d组、缺氧3 d组上述指标和缺氧4 d组比较,在统计学上差异均有统计学意义(均P<0.05).结论 不同的高原缺氧环境对BBB中ABC族转运蛋白的表达产生不同的影响,并影响其底物药物在体内的药物浓度.
Effects of high altitude hypoxia on the expression of ATP-binding cassette transporter in blood-brain barrier
Objective This study aimed to investigate the effects of high-altitude hypoxia on the expression of ATP-binding cassette(ABC)transport proteins in the blood-brain barrier(BBB)and explore the mechanisms influencing their expression.Methods Wistar rats were divided into 1500 m group(Lanzhou field),4010 m group(simulated 4010 m,low-pressure oxygen chamber,hypoxia for 3 days),6000 m group(simulated 6000 m,low-pressure oxygen chamber,hypoxia for 3 days),phenytoin sodium+1500 m group(given 50 mg·kg-1 phenytoin sodium on the basis of the 1500 m group),phenytoin sodium+4010 m group(given 50 mg·kg-1 phenytoin sodium on the basis of the 4010 m group),phenytoin sodium+6000 m group(given 50 mg·kg-1 phenytoin sodium on the basis of the 6000 m group),and hypoxia 1 d group,hypoxia 2 d group,hypoxia 3 d group,hypoxia 4 d group(simulated altitude of 4010 m,low-oxygen chamber,hypoxia for 1,2,3,4 days).Western blot was used to detect the expression of BBB tissue proteins;and liquid chromatography-tandem mass spectrometry was used to measure the concentration of phenytoin sodium in cerebrospinal fluid.Results The relative expression levels of P-glycoprotein(P-gp)in the 1500 m,4010 m,6000 m groups were 1.00±0.04,1.84±0.02,2.10±0.05,respectively;the relative expression levels of multidrug resistance-associated protein-4(MRP4)were 1.00±0.05,2.77±0.08,4.42±0.03,respectively;the concentrations of phenytoin sodium in cerebrospinal fluid were(864.78±348.32),(1 000.22±273.90),and(1 214.17±314.09)ng·mL-1,respectively.The differences in the above indicators between the 1500 m,4010 m,and 6000 m groups were statistically significant(all P<0.05).The relative expression levels of P-gp in the hypoxia 1 d,2 d,3 d,4 d groups were 1.00±0.03,1.85±0.04,3.10±0.02,2.17±0.05,respectively;the relative expression levels of MRP4 were 1.00±0.05,1.79±0.10,1.60±0.08,1.31±0.06,respectively;the differences in the above indicators between the hypoxia 1 d,2 d,3 d,4 d groups were statistically significant(all P<0.05).Conclusion Different high-altitude hypoxic environments have different effects on the expression of ABC transport proteins in the BBB,influencing the drug concentrations of their substrate drugs in the body.

phenytoin sodiumhigh altitude hypoxiablood brain barrierP-glycoproteinmultidrug resistance associated protein-4breast cancer resistance proteincerebrospinal fluid

张明霞、张强、李文斌、胥艳梅、王荣

展开 >

中国人民解放军联勤保障部队第940医院药剂科,甘肃兰州 730050

中国人民解放军联勤保障部队第940医院卫勤训练中心,甘肃兰州 730050

苯妥英钠 高原缺氧 血脑屏障 P-糖蛋白 多药耐药相关蛋白-4 乳腺癌耐药蛋白 脑脊液

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(10)
  • 13